GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-022980 |
|---|---|
| Form Type | 4 |
| Filing Date | May 27, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
22,500
Total Value
$51,305.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 22, 2026 | Exercise/Conversion | 3,500 | $0.75 | $2,625.00 | 703,500 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 22, 2026 | Sale | 3,500 | $6.08 | $21,280.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Exercise/Conversion | 4,000 | $0.75 | $3,000.00 | 704,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 26, 2026 | Sale | 4,000 | $6.10 | $24,400.40 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 22, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 901,395 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 26, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 897,395 | Direct | โ | View Details |